Found: 3

Select item for more details and to access through your institution.

  • Preclinical development of AMG 139, a human antibody specifically targeting IL-23.

    Published in:
    British Journal of Pharmacology, 2015, v. 172, n. 1, p. 159, doi. 10.1111/bph.12904
    By:
    • Köck, K;
    • Pan, W J;
    • Gow, J M;
    • Horner, M J;
    • Gibbs, J P;
    • Colbert, A;
    • Goletz, T J;
    • Newhall, K J;
    • Rees, W A;
    • Sun, Y;
    • Zhang, Y;
    • O'Neill, J C;
    • Umble ‐ Romero, A N;
    • Prokop, S P;
    • Krill, C D;
    • Som, L;
    • Buntich, S A;
    • Trimble, M W;
    • Tsuji, W H;
    • Towne, J E
    Publication type:
    Article

  • OII-B-4<sup>*</sup>.

    Published in:
    Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P6, doi. 10.1016/j.clpt.2005.12.017
    By:
    • Chinn, L. W.;
    • Gow, J. M.;
    • Becker, S. L.;
    • Tse, M. M.;
    • Kroetz, D. L.
    Publication type:
    Article

  • Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression.

    Published in:
    Pharmacogenomics Journal, 2013, v. 13, n. 5, p. 396, doi. 10.1038/tpj.2012.20
    By:
    • Nguyen, T D;
    • Markova, S;
    • Liu, W;
    • Gow, J M;
    • Baldwin, R M;
    • Habashian, M;
    • Relling, M V;
    • Ratain, M J;
    • Kroetz, D L
    Publication type:
    Article